日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy

用于协同癌症免疫治疗的癌细胞特异性促凋亡SMAC肽-阿霉素偶联前药封装脂质体

Jinseong Kim # ,Man Kyu Shim # ,Yujeong Moon ,Jeongrae Kim ,Hanhee Cho ,Wan Su Yun ,Nayeon Shim ,Joon-Kyung Seong ,Yonghyun Lee ,Dong-Kwon Lim ,Kwangmeyung Kim

All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy

用于癌症免疫治疗中阿霉素和抗PD-L1肽共递送的一体化乙二醇壳聚糖纳米颗粒

Sukyung Song ,Man Kyu Shim ,Suah Yang ,Jaewan Lee ,Wan Su Yun ,Hanhee Cho ,Yujeong Moon ,Jin Young Min ,Eun Hee Han ,Hong Yeol Yoon ,Kwangmeyung Kim

Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy

微注射器芯片引导脂质纳米粒子肿瘤内给药用于靶向抗癌治疗

Jeongrae Kim #, Sunejeong Song #, Minjun Gwak #, Hanhee Cho, Wan Su Yun, Namcheol Hwang, Jinseong Kim, Jun Seo Lee, Dong-Hwee Kim, Hyuncheol Kim, Seong Ik Jeon, Tae-Il Kim, Kwangmeyung Kim

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death

用于靶向癌症免疫疗法的抗PD-L1肽偶联前药纳米颗粒,结合了PD-L1阻断和免疫原性细胞死亡。

Yujeong Moon ,Man Kyu Shim ,Jiwoong Choi ,Suah Yang ,Jinseong Kim ,Wan Su Yun ,Hanhee Cho ,Jung Yeon Park ,Yongju Kim ,Joon-Kyung Seong ,Kwangmeyung Kim

Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy

肿瘤特异性单甲基奥瑞他汀 E (MMAE) 前药纳米粒子用于安全有效的化疗

Hanhee Cho, Man Kyu Shim, Yujeong Moon, Sukyung Song, Jinseong Kim, Jiwoong Choi, Jeongrae Kim, Youngjoo Lee, Jung Yeon Park, Yongju Kim, Cheol-Hee Ahn, Mi Ra Kim, Hong Yeol Yoon, Kwangmeyung Kim